Dorsey Wright & Associates Catalent, Inc. Transaction History

Dorsey Wright & Associates

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$100.34 - $115.69 $3.49 Million - $4.03 Million	-34,800 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$101.51 - $125.27 $65,473 - $80,799	645 Added 1.89%	34,800 $3.67 Million
Q4 2020 Jan 28, 2021	BUY	$85.88 - $105.36 $96,786 - $118,740	1,127 Added 3.41%	34,155 $3.56 Million
Q3 2020 Oct 28, 2020	SELL	$72.74 - $92.5 $212,255 - $269,915	-2,918 Reduced 8.12%	33,028 $2.83 Million
Q2 2020 Jul 23, 2020	SELL	$48.02 - $79.04 $3,985 - $6,560	-83 Reduced 0.23%	35,946 $2.64 Million

Q1 2020 Apr 20, 2020	SELL	$36.95 - $62.95 $68,135 - $116,079	-1,844 Reduced 4.87%	36,029 $1.87 Million
Q4 2019 Jan 31, 2020	SELL	$47.06 - $56.64 $1.38 Million - $1.66 Million	-29,319 Reduced 43.63%	37,873 $2.13 Million
Q3 2019 Oct 31, 2019	BUY	$47.45 - $58.05 $3.19 Million - $3.9 Million	67,192 New	67,192 $3.2 Million

485

172M

865K

687K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.2B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.